Displaying items by tag: Perrigo Co plc
GRAND RAPIDS — Executives at Perrigo Co. plc believe the company’s new North American headquarters will fit in neatly with the city of Grand Rapids’ burgeoning health care sector along Medical Mile.
GRAND RAPIDS — Perrigo Co. plc is relocating its North American corporate headquarters to downtown Grand Rapids, MiBiz has learned.
MiBiz growth report for August 16, 2020.
ALLEGAN — Perrigo Co. plc intends to buy three skin care and hair loss brands from French pharmaceutical company Sanofi.
Perrigo Co. plc grew sales more than 6 percent in the second quarter as earlier high demand eased for some medications during the COVID-19 pandemic.
Here is the MiBiz Growth Report for June 21, 2020.
Perrigo Co. plc has sold its generic prescription drug business to United Kingdom-based Rosemont Pharmaceuticals Ltd for $195 million in cash.
Perrigo Co. plc plans to enter the CBD market through a strategic investment and a long-term agreement with a Colorado supplier.
ALLEGAN — Higher consumer demand to treat symptoms of COVID-19 pushed Perrigo Co. plc to a 14-percent increase in sales growth for the first quarter.
ALLEGAN — Perrigo Co. plc recorded strong double-digit sales growth for the first quarter, as demand spiked for over-the-counter medications in March in the COVID-19 pandemic.